Electroconvulsive therapy (ECT) is a well-established, effective somatic treatment primarily used in psychiatry for severe depression and other psychiatric conditions such as bipolar disorder and schizophrenia, demonstrating faster and sometimes superior clinical responses compared to pharmacotherapy NICE NG222,Pathak et al. 2026 Haynes et al. 2025 Pathak et al. 2026. Despite its efficacy and rapid action, ECT remains notably underutilized, largely due to persistent stigma and misconceptions surrounding its use NICE NG222 Haynes et al. 2025.
Stigma associated with ECT is multifaceted, encompassing societal, patient, and provider-level biases. Negative attitudes towards ECT are often driven by historical misuse, misleading media portrayals, and lack of accurate knowledge concerning the procedure, its efficacy, and safety profile NICE NG222 Haynes et al. 2025 Pathak et al. 2026. This stigma creates significant barriers to access, with patients and providers sometimes viewing ECT as a 'last-resort' or coercive treatment despite contemporary guidelines recommending it as a first-line option in specific urgent clinical situations NICE NG222 Haynes et al. 2025 Pathak et al. 2026.
Patient knowledge deficits contribute substantially to stigmatizing attitudes. For example, patients with bipolar disorder were found to have incomplete understanding of ECT's mechanisms, treatment cycles, and neurobiological benefits, leading to predominantly negative attitudes despite a moderate willingness to consider ECT when adequately informed Zhou et al. 2025. Improving knowledge is key: greater patient understanding positively correlates with improved attitudes and increased willingness to accept ECT Zhou et al. 2025. Similarly, tailored educational interventions for healthcare providers, such as interactive workshops focusing on ECT referral assessment and stigma reduction, have demonstrated increased confidence in addressing stigma and making appropriate referrals for depressed patients Haynes et al. 2025.
Provider attitudes also shape access to ECT. Misconceptions about side effects, especially cognitive risks, and incomplete training on ECT indications contribute to reluctance in recommending this treatment Haynes et al. 2025. Variability in ECT education worldwide, including limited training hours and inconsistent clinical exposure for psychiatry trainees, exacerbates this issue and perpetuates stigma within clinical practice Haynes et al. 2025 Pathak et al. 2026. In India, for example, research shows that outdated equipment, inconsistent monitoring, and regulatory hurdles compound stigma and service inequality, highlighting systemic as well as educational challenges Pathak et al. 2026.
Addressing stigma requires a multifaceted approach. Educational programs that engage both emotions and cognitive understanding — using patient stories, interactive case discussions, and reflective practice — have proven effective in reducing stigma and improving knowledge and attitudes among trainees and providers Haynes et al. 2025. Patient-focused educational initiatives tailored to address specific concerns, dispel myths, and highlight safety and efficacy can shift negative perceptions, notably by clarifying misconceptions about side effects and procedure details Zhou et al. 2025 Pathak et al. 2026. Incorporating patient testimonials and culturally sensitive communication further fosters acceptance Pathak et al. 2026.
System-level factors also influence stigma and access. Regulatory frameworks, such as the Indian Mental Healthcare Act 2017, imposing restrictions on unmodified ECT and requiring additional oversight, while ethically motivated, can unintentionally limit availability, especially in resource-limited settings, and accentuate stigma by casting ECT as risky or exceptional Pathak et al. 2026. Additionally, lack of infrastructure, anesthesia support, and disparities in healthcare provision, particularly in rural or underserved areas, affect equitable access and perpetuate stigma Pathak et al. 2026.
Overall, stigma around ECT arises from a complex interplay among knowledge gaps, cultural attitudes, media-driven misconceptions, provider education deficits, and systemic barriers. Addressing these challenges through targeted education, improved training, transparent communication, and policy adjustments is essential to normalize ECT as a safe, effective treatment, reduce stigma, and optimize access and outcomes for patients with severe psychiatric illnesses NICE NG222 Haynes et al. 2025 Zhou et al. 2025 Pathak et al. 2026.
Key References
- NICE NG222: Depression in adults: treatment and management
- NICE CKS: Schizophrenia and psychosis
- (Sartorius and Henn, 2005): [Treating depressive disorders with continuation electroconvulsive therapy].
- (Haynes et al., 2025): Electroconvulsive Therapy (ECT) Referral Workshop for Depression: Assessing Patients and Addressing Stigma.
- (Zhou et al., 2025): Knowledge, attitudes, and willingness of bipolar disorder patients toward electroconvulsive therapy: a cross-sectional study.
- (Pathak et al., 2026): Electroconvulsive therapy research in India: A scoping review.